$2.95 - ANVS | Annovis Bio, Inc.

Annovis Bio, Inc. (ANVS)

Annovis Bio, Inc.

XNYS:ANVS

2.95

-7.81%

Ask

$7.00 - 45.00

Bid

$2.89 - 606.00

Low

$2.89

High

$3.26

Open

$3.22

Prev Close

$3.2

52W High

5.5

52W Low

1.11

Volume

835496

Avg Vol (3m)

571748.6

Float

22408095.94

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 01/29/2020

Primary Exchange: XNYS

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Phone: 484-875-3192

Address: 101 Lindenwood Drive, Suite 225

City: Malvern

State: PA

Postal Code: 19355

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-2.160000

P/B (TTM)

4.910310

Round Lot

100

Composit FIGI

BBG00PN9XD40

Share Class FIGI

BBG00PN9XDJ4

Share Class Shares Outstanding

19.49M

Weighted Shares Outstanding

26.11M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion